Arkema S.A. (OTCMKTS:ARKAY - Get Free Report) shares reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $64.94 and last traded at $73.75, with a volume of 77303 shares trading hands. The stock had previously closed at $66.40.
Arkema Stock Performance
The business's fifty day moving average price is $81.53 and its 200-day moving average price is $81.86. The stock has a market cap of $5.31 billion, a PE ratio of 13.95, a P/E/G ratio of 0.53 and a beta of 1.18. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.54 and a current ratio of 2.11.
Arkema Company Profile
(
Get Free Report)
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
Featured Stories
Before you consider Arkema, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.
While Arkema currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
